Sarcolemmal ATP-sensitive potassium channel (sKATP) (sKATP)

The sarcolemmal ATP-sensitive potassium (sKATP) channel is a hetero-octameric protein complex that functions as a metabolic sensor, coupling intracellular energy status to membrane excitability [UniProt P48048, Q14654]. In vascular smooth muscle, the channel typically consists of Kir6.1 and SUR2B subunits, where its activation leads to membrane hyperpolarization, closure of voltage-gated calcium channels, and subsequent vasodilation [Circulation Research, 2012]. In cardiomyocytes, the channel is primarily composed of Kir6.2 and SUR2A subunits and plays a vital role in cardioprotection by shortening the action potential duration during metabolic stress or ischemia, thereby reducing calcium overload [Journal of Molecular and Cellular Cardiology, 2016]. These channels are therapeutic targets for various cardiovascular conditions; for instance, potassium channel openers (KCOs) like minoxidil and nicorandil are used to treat hypertension and angina by promoting channel opening [StatPearls, 2023]. Conversely, sulfonylureas like glibenclamide act as inhibitors, though they are more selective for pancreatic KATP channels in clinical use for diabetes [PubChem]. Genetic variations in the subunits, particularly ABCC9, are linked to pathologies such as Cantu syndrome and coronary vasospasm [NIH, 2021]. The channel's ability to respond to the ATP/ADP ratio allows it to adjust muscle tone and cardiac work in response to the body's metabolic demands. Pharmacological modulation of these channels requires careful selectivity to avoid off-target effects on the endocrine system, specifically insulin secretion.

Other names

Sarcolemmal KATP channelsKATP channelATP-sensitive inward rectifier potassium channelKir6.x/SUR2 complex

Potassium channel openers (KCOs) bind to the sulfonylurea receptor (SUR) subunits, increasing the open-state probability of the channel, leading to potassium efflux, membrane hyperpolarization, and subsequent relaxation of smooth muscle or reduction of action potential duration in cardiomyocytes [StatPearls, 2023].